Net Cash Provided by (Used in) Financing Activities in USD of Korro Bio, Inc. from 2017 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Korro Bio, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2017 to Q1 2025.
  • Korro Bio, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was $172K, a 23.7% increase year-over-year.
  • Korro Bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $69.4M, a 63.1% decline from 2023.
  • Korro Bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $188M, a 1043017% increase from 2022.
  • Korro Bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $18K, a 98.7% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

Korro Bio, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $172K +$33K +23.7% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-07
Q1 2024 $139K -$45.3M -99.7% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-07
Q1 2023 $45.4M +$45.2M +22601% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q1 2022 $200K -$372K -65% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q1 2021 $572K +$263K +85.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q1 2020 $309K -$33K -9.65% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q1 2019 $342K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14

Korro Bio, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $69.4M -$118M -63.1% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-18
2023 $188M +$188M +1043017% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-18
2022 $18K -$1.34M -98.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 $1.36M -$55.3M -97.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-10
2020 $56.7M -$85.3M -60.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2019 $142M +$100M +240% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-29
2018 $41.7M +$13.7M +49.1% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-26
2017 $28M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.